Lanzhou Foci Pharmaceutical Co Ltd (002644) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.041x

Based on the latest financial reports, Lanzhou Foci Pharmaceutical Co Ltd (002644) has a cash flow conversion efficiency ratio of 0.041x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥75.62 Million ≈ $11.07 Million USD) by net assets (CN¥1.85 Billion ≈ $270.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Lanzhou Foci Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Lanzhou Foci Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Lanzhou Foci Pharmaceutical Co Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.

Lanzhou Foci Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Lanzhou Foci Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Voyageurs du Monde SA PA:ALVDM	0.434x
Caisse Regionale de Credit Agricole Mutuel de Normandie Seine SC PA:CCN	0.003x
RVRC Holding AB ST:RVRC	0.298x
Suzhou GYZ Electronic Technology Co. Ltd. A SHG:688260	0.057x
Anhui Huamao Textile Co Ltd SHE:000850	0.115x
HomeTrust Bancshares, Inc. NASDAQ:HTB	0.127x
Betterware de MÃ©xico, S.A.P.I. de C.V. NYSE:BWMX	0.442x
BizConf Telecom Co Ltd SHE:300578	0.003x

Annual Cash Flow Conversion Efficiency for Lanzhou Foci Pharmaceutical Co Ltd (2007–2024)

The table below shows the annual cash flow conversion efficiency of Lanzhou Foci Pharmaceutical Co Ltd from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see 002644 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.81 Billion ≈ $265.59 Million	CN¥38.98 Million ≈ $5.70 Million	0.021x	-42.20%
2023-12-31	CN¥1.77 Billion ≈ $258.78 Million	CN¥65.71 Million ≈ $9.62 Million	0.037x	-10.97%
2022-12-31	CN¥1.73 Billion ≈ $253.73 Million	CN¥72.37 Million ≈ $10.59 Million	0.042x	+472.99%
2021-12-31	CN¥1.63 Billion ≈ $238.15 Million	CN¥11.85 Million ≈ $1.73 Million	0.007x	-81.62%
2020-12-31	CN¥1.59 Billion ≈ $232.24 Million	CN¥62.89 Million ≈ $9.20 Million	0.040x	+24.86%
2019-12-31	CN¥1.51 Billion ≈ $220.51 Million	CN¥47.82 Million ≈ $7.00 Million	0.032x	+24.68%
2018-12-31	CN¥1.44 Billion ≈ $210.78 Million	CN¥36.66 Million ≈ $5.36 Million	0.025x	-47.92%
2017-12-31	CN¥1.36 Billion ≈ $198.89 Million	CN¥66.42 Million ≈ $9.72 Million	0.049x	+10.85%
2016-12-31	CN¥1.29 Billion ≈ $188.85 Million	CN¥56.90 Million ≈ $8.33 Million	0.044x	-15.17%
2015-12-31	CN¥1.23 Billion ≈ $180.52 Million	CN¥64.11 Million ≈ $9.38 Million	0.052x	-59.24%
2014-12-31	CN¥735.22 Million ≈ $107.59 Million	CN¥93.75 Million ≈ $13.72 Million	0.128x	+956.24%
2013-12-31	CN¥703.37 Million ≈ $102.93 Million	CN¥-10.47 Million ≈ $-1.53 Million	-0.015x	+8.69%
2012-12-31	CN¥675.53 Million ≈ $98.85 Million	CN¥-11.02 Million ≈ $-1.61 Million	-0.016x	-535.65%
2011-12-31	CN¥648.08 Million ≈ $94.84 Million	CN¥2.43 Million ≈ $355.00K	0.004x	-97.82%
2010-12-31	CN¥326.46 Million ≈ $47.77 Million	CN¥56.18 Million ≈ $8.22 Million	0.172x	+1156.35%
2009-12-31	CN¥252.96 Million ≈ $37.02 Million	CN¥3.46 Million ≈ $507.01K	0.014x	+392.85%
2008-12-31	CN¥216.81 Million ≈ $31.73 Million	CN¥602.56K ≈ $88.17K	0.003x	-99.49%
2007-12-31	CN¥195.20 Million ≈ $28.56 Million	CN¥105.61 Million ≈ $15.45 Million	0.541x	--

About Lanzhou Foci Pharmaceutical Co Ltd

SHE:002644 China Drug Manufacturers - Specialty & Generic

Market Cap

$626.94 Million

CN¥4.28 Billion CNY

Market Cap Rank

#11375 Global

#3431 in China

Share Price

CN¥8.39

Change (1 day)

+2.07%

52-Week Range

CN¥7.79 - CN¥11.76

All Time High

CN¥18.02